Name (Synonyms) | Correlation | |
---|---|---|
drug1019 | serological test Wiki | 1.00 |
drug681 | Rapid molecular test Wiki | 1.00 |
drug1020 | serum chemistry analysis Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Translational, prospective / retrospective, non-profit, non-pharmacological study, with cohort characteristics. The study consists of two parts: the first to study epidemiological aspects of the spread of the disease and the second one to identify infection-related genetic factors.
Description: Investigate the epidemiology of the infection in an asymptomatic population including both healthy individuals at high risk of infection and oncological patients by assessing the seroprevalence of IgG and IgM antibodies against the SARS-CoV-2
Measure: epidemiology Time: 12 monthsDescription: IgG and IgM antibodies evaluation over time
Measure: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) antibodies evaluation Time: 12 monthsDescription: Make a comparison between different serological investigation methods and rapid molecular methods becoming available
Measure: methods comparison Time: 24 monthsDescription: To evaluate correlation between biochemical and coagulative factors with SARS-CoV-2 positivity
Measure: correlation between biochemical and coagulative factors with SARS-CoV-2 positivity. Time: 24 monthsDescription: Building a phylogenetic map of an epidemic Italian macro-region
Measure: phylogenetic map Time: 24 monthsDescription: Evaluate the spectrum of possible interactions between the virus and host cells, considering their genetic variability / instability in patients diagnosed with COVID-19
Measure: interactions between the virus and host cells Time: 24 months